• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. Personalized Medicine is the Future

    Gen-Probe's CFO Herm Rosenman says the firm has plenty of catalysts that should drive growth for the next several years.

  2. Behind the Bullish Take on Our Top Pharma Pick

    A large generics business and niche pipeline keep Novartis ahead of the curve.

  3. Healthy Growth Prospects for This Pharma Pick

    Day 7: Growth from emerging markets as well as launched and pipeline products bode well for this pick.

  4. An Opportunistic Pharma Pick

    Premature disappointment over the prospect of Vanda's sole drug has left investors with a compelling opportunity says Morningstar Opportunistic Investor's Stephen Ellis.

  1. Look Out, BRICs–Here Come the TIMPs

     

  2. Wait for Your Pitch in Today’s Market

     

  3. Top Dividend-Paying Stocks Held by Our Ultimate Stock-Pickers

    While Warren Buffett may have put the kibosh on a dividend for Berkshire's shareholders, he and the rest of our Ultimate Stock-Pickers continue to hold stocks yielding more than the S&P 500 Index.

  4. Breaking Bad Behaviors

     

1
ShareEmail
Print
Text Size
Comment
blog comments powered by Disqus
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.